RGH-478

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameRGH-478
Drug Alias NameRGH-478
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBradykinin B1 receptor antagonists
TargetsBradykinin B1 receptor
Therapy Area/IndicationsMusculoskeletal PainOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGedeon Richter
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGedeon Richter Plc
Active IndicationsN/A
Inactive IndicationsMusculoskeletal PainOsteoarthritis

Other Information

ATC CodeN/A
Related LinksN/A